10X Genomics has patented a microfluidic system for encapsulating reagents in droplets for biological analyses. The system includes fluid sources, an agitating component, and a flow control system to generate droplets containing microcapsules. This innovation enhances efficiency in biological characterization processes. GlobalData’s report on 10X Genomics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights 10X Genomics Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on 10X Genomics, ChIP-seq sequencing was a key innovation area identified from patents. 10X Genomics's grant share as of May 2024 was 15%. Grant share is based on the ratio of number of grants to total number of patents.

Microfluidic system for encapsulated reagents generation and partitioning

Source: United States Patent and Trademark Office (USPTO). Credit: 10X Genomics Inc

A recently granted patent (Publication Number: US12005454B2) discloses a novel microfluidic system designed for generating droplets containing microcapsules. The system comprises a first fluid source with an aqueous fluid and microcapsules, an agitating component, a second fluid source with an immiscible fluid, and a droplet generation junction. A flow control system, including independently controlled pressure sources, facilitates the flow of the first and second fluids to meet at the junction, resulting in the generation of droplets containing microcapsules that flow along a designated channel. Additionally, the system can incorporate a third fluid source with an additional aqueous fluid, further expanding its capabilities for creating mixtures of fluids.

Furthermore, the microfluidic system described in the patent includes features such as an agitating component to prevent settling of microcapsules, the encapsulation of reagents within the microcapsules, and the use of barcode sequences as reagents. The system's versatility is enhanced by the ability to control the flow of multiple fluids independently, ensuring precise manipulation of droplet generation and fluid mixing processes. Additionally, the agitating component can be piezoelectric, acoustic, or mechanical, providing flexibility in the system's design and operation. Overall, the patented microfluidic system offers a sophisticated and efficient solution for generating droplets containing microcapsules and conducting various fluid-based experiments with high precision and control.

To know more about GlobalData’s detailed insights on 10X Genomics, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.